Adherence
Cycling as a mode of active commuting is associated with significantly lower risks of all-cause mortality, cardiovascular disease (CVD) incidence and mortality, and cancer incidence and mortality compared to non-active commuting.
If you can, cycle to work. This study links cycling to significantly lower risks of heart disease, cancer, and death. You don't need to be a pro; even mixed-mode commuting (cycling part of the way) helps. If cycling isn't possible, walking to work also reduces heart disease risk, especially if you walk longer distances.
Cycle commuting was associated with a lower risk of CVD, cancer, and all cause mortality.
Why this rating
Large prospective cohort (UK Biobank, n=263,540) with long follow-up and adjustment for many confounders, though observational design limits causal inference.
Source
Association between active commuting and incident cardiovascular disease, cancer, and mortality: prospective cohort study
Carlos Celis‐Morales et al. · BMJ · 2017
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →